Should all children with cystic fibrosis who have responsive CFTR mutations be prescribed CFTR modulators?

J Cyst Fibros. 2023 Dec 4:S1569-1993(23)01682-X. doi: 10.1016/j.jcf.2023.11.011. Online ahead of print.

Author

Affiliation

¹ Children's Bioethics Centre, Royal Children's Hospital, 50 Flemington Road, Parkville, 3052, Victoria, Australia; Department of Respiratory Medicine, Royal Children's Hospital, Australia; Department of Paediatrics, University of Melbourne, Australia; Murdoch Childrens Research Institute, Melbourne, Australia. Electronic address: john.massie@rch.org.au.

PMID: 38052705
DOI: 10.1016/j.jcf.2023.11.011

No abstract available

Keywords: CFTR modulators; Cystic fibrosis; Ethics.

Publication types

Review